Source recordFED

Acasti Pharma Inc

Federal grants & contributions· Industrial Research Assistance Program – Contributions to Firms· National Research Council Canada· FY2020· $326,357· BN 864885652· QC

Description

The project involves the commercial scale-up of certain components of the CaPre manufacturing process and aims to achieve a level of production capable of meeting the expected demand at the time of commercialization.

Amendment chain · 2 entries

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $750,000 at start, $326,357 after amendment #2 (−$423,643).

$750,000$0Original · 2019-07-01 (start date) · total $750,000Amendment 2 · 2020-10-29 · total $326,357
  • #02019-07-01$750,000
  • #22020-10-29$326,357-$423,643
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2019-07-01(start date)$750,000—The project involves the commercial scale-up of certain components of the CaPre manufacturing process and aims…
#2 amendment2020-10-29$326,357−$423,643The project involves the commercial scale-up of certain components of the CaPre manufacturing process and aims…

Related records · 6

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other current agreements for the same recipient (business number 864885652)

RefDepartment · programCurrent valueFY
172-2018-2019-Q1-906423National Research Council Canada | Conseil national de recherches Canada · Industrial Research Assistance Program – Green Youth Employment Program$10,000FY2019

Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)

RefRecipientFiscal yearCurrent valueFY
172-2025-2026-Q2-1034675Mediphage Bioceuticals, Inc.FY2027$63,380FY2027
172-2025-2026-Q3-1037522OBKIO INC.FY2026$50,000FY2026
172-2025-2026-Q3-1037889SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INCFY2026$25,000FY2026
172-2025-2026-Q2-1034040Griffith Foods LimitedFY2026$54,880FY2026
172-2025-2026-Q3-1037273Apollo Machine & Welding Ltd.FY2026$230,000FY2026

Cite as: Glassbox record view · Federal grants & contributions · 172-2019-2020-Q2-933064 · retrieved 2026-11-15.